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The essential Mycobacterium tuberculosis Ser/Thr
protein kinase (STPK), PknB, plays a key role in
regulating growth and division, but the structural
basis of activation has not been defined. Here, we
provide biochemical and structural evidence that
dimerization through the kinase-domain (KD)
N-lobe activates PknB by an allosteric mechanism.
Promoting KD pairing using a small-molecule dimer-
izer stimulates the unphosphorylated kinase, and
substitutions that disrupt N-lobe pairing decrease
phosphorylation activity in vitro and in vivo. Multiple
crystal structures of two monomeric PknB KD
mutants in complex with nucleotide reveal diverse
inactive conformations that contain large active-site
distortions that propagate >30 A˚ from the mutation
site. These results define flexible, inactive structures
of a monomeric bacterial receptor KD and show how
‘‘back-to-back’’ N-lobe dimerization stabilizes the
active KD conformation. This general mechanism of
bacterial receptor STPK activation affords insights
into the regulation of homologous eukaryotic kinases
that form structurally similar dimers.
INTRODUCTION
Protein phosphorylation mediated by receptor Ser/Thr protein
kinases (STPKs) is widely used to transduce extracellular signals
into intracellular responses. In contrast to the regulation of
eukaryotic receptor STPKs (Huse and Kuriyan, 2002) the control
mechanisms of prokaryotic family members are not well under-
stood. In bacteria, eukaryotic-like STPKs are especially preva-
lent in pathogens (Cozzone, 2005). Ser/Thr phosphorylationStructure 18, 1667–16prompts numerous, broad effects, including changes in tran-
scription, metabolic flux, cell growth, cell division, protein local-
ization, and immune defense/pathogenesis (Kang et al., 2008;
Park et al., 2008; Sharma et al., 2006b; Thakur and Chakraborti,
2006; Williams, 1999), each requiring precise regulation of
kinases for accurate signal transduction.
In Mycobacterium tuberculosis (Mtb), for example, STPKs
have been estimated to phosphorylate several hundred proteins
(Greenstein et al., 2005), and over 250 Ser/Thr phosphoproteins
have been identified recently (Chao et al., 2010; Prisic et al.,
2010). While two of the 11 Mtb STPKs are soluble kinases,
nine are predicted transmembrane receptors with an N-terminal
‘‘eukaryotic-like’’ kinase domain (KD) linked through a single
transmembrane helix to an extracellular sensor domain
(Av-Gay and Everett, 2000). Orthologs of the Mtb transmem-
brane receptor Protein Kinase B (PknB) are the most widely
distributed STPKs in the prokaryotic kingdom (Jones and Dyson,
2006). PknB is essential for Mtb growth (Fernandez et al., 2006;
Sassetti et al., 2003), and it phosphorylates diverse substrates,
including proteins involved in peptidoglycan synthesis (Parikh
et al., 2009), cell division (Dasgupta et al., 2006), the stress
response (Park et al., 2008), transcription (Sharma et al.,
2006a), metabolic control (O’Hare et al., 2008), and other STPKs
(Kang et al., 2005; Prisic et al., 2010). A key challenge is to under-
stand how bacterial receptor STPKs such as PknB respond to
extracellular signals.
The PknB KD structure, the first of a bacterial STPK, showed
that characteristic features of the active conformations of
eukaryotic STPKs are conserved in bacterial family members
(Ortiz-Lombardia et al., 2003; Young et al., 2003). Like many
eukaryotic STPKs, autophosphorylation of a sequence element
called the activation loop strongly stimulates PknB kinase
activity (Boitel et al., 2003). The KD contains characteristic
N- and C-lobes that bracket the ATP binding site. The KD forms
a back-to-back dimer through a conserved interface in the
N-lobe. A functional role for the N-lobe interface was supported
by the finding that theMtb PknE KD crystallized as a structurally77, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1667
Table 1. N-Lobe Dimer Interface Mutations Affect PknB Autophosphorylation
PknB Mutant Calculated Mass (Da) Observed Masses (Da)a PO4 sites
PknB-FKBP 47,875.0 48,399.0 (avg. of 6P & 7P)b,c NDd
Arg10Ala-FKBP 47,789.9 48,186 (5P), 48,113 & 48,273 (4P & 6P), 48,045 & 48,376 (3P & 7P) ND
Leu33Asp-FKBP 47,876.9 48,114.9 (3P), 48,033.0 (2P) T171, T173, T294
Asp76Ala-FKBP 47,831.0 48,067.2 (3P), 47,988.0 (2P) T171, T173, T294
Asp138Asn-FKBP 47,874.0 47,873.1 (0P) None
Asp138Asn1-308 33,478.7 33,480.4 (0P) None
a The species are listed in order of abundance, and the number of phosphates (P) is indicated in parentheses.
b The species with molecular mass 48,399.0 (representing an average of six to seven phosphates) was the most abundant species.
c A molecular mass of 48,350.0 (6P) was the lowest molecular weight species observed.
dND, not determined in this study.
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Allosteric Mechanism of PknB Activationanalogous dimer despite divergence of the intersubunit contact
residues (Gay et al., 2006). Remarkably, structurally analogous
dimers are formed by certain human STPKs including PKR, the
cytosolic dsRNA-dependent protein kinase (Dar et al., 2005),
and Ire1, which mediates the unfolded protein response (Lee
et al., 2008). Dimerization through the N-lobe activates PKR
and related kinases (Dey et al., 2005, 2007), as well as the Mtb
PknD KD in vitro (Greenstein et al., 2007), suggesting that struc-
turally and functionally similar interfaces regulate these STPKs.
The structures of the monomeric forms of these eukaryotic and
bacterial KDs, however, have not been reported.
To establish the role of the PknB N-lobe dimer interface and
determine the conformational changes associated with dimer
formation, we characterized the activities and structures of
monomeric PknB mutants. We show here that dimerization of
the unphosphorylated PknB KD promotes auto- and trans-phos-
phorylation in vitro. Mutations that disrupt the N-lobe interface
decrease protein phosphorylation inMycobacterium smegmatis
strains expressing full-lengthMtb PknB, establishing that N-lobe
interactions are required for substrate phosphorylation in vivo.
To discover the structural basis of this shared activation mecha-
nism, we determined multiple crystal structures of PknB KD
N-lobe interface mutants. Rather than adopting a single confor-
mation, these mutant monomers populate diverse conforma-
tions containing hallmarks of ‘‘inactive’’ eukaryotic STPKs,
including extensive remodeling of the active site. The unex-
pected variations in these structures reveal the flexibility of a
monomeric bacterial receptor STPK. This work supports a
general model for regulation of structurally homologous bacterial
and eukaryotic kinases in which a flexible, inactive monomer
shifts to the active conformation by dimerization and
autophosphorylation.
RESULTS
Although the wild-type PknB KD crystallized as a dimer with
intersubunit contacts mediated by conserved residues (Ortiz-
Lombardia et al., 2003; Young et al., 2003), the affinity and the
function of the dimer have not been established. Equilibrium
analytical ultracentrifugation experiments show that the phos-
phorylated intracellular domain of PknB1-330 (comprising the
KD and juxtamembrane linker) has an apparent dissociation
constant of 2.9 mM (see Figure S1 available online). Because
the interaction is weak, an inducible dimerization system was1668 Structure 18, 1667–1677, December 8, 2010 ª2010 Elsevier Ltdused to control the association of the KD in vitro and determine
the impact of dimerization on phosphoryl transfer activity. We
adapted the system previously used to study dimerization of
the PknD KD (Greenstein et al., 2007) by constructing C-terminal
fusions of PknB1-330 with the FK506-binding protein (FKBP) or
the FKBP-rapamycin-binding (FRB) domain of the FKBP-
rapamycin-associated protein (Brown et al., 1994; Choi et al.,
1996). In this system, the small-molecule rapamycin promotes
association of the FKBP and FRB domains, increasing the
local concentration of the attached PknB KDs (Clemons, 1999;
Crabtree and Schreiber, 1996).
Recombinant PknB1-330-FKBP purified from Escherichia coli
contained two predominant species carrying six or seven phos-
phates, as indicated by mass spectrometry (Table 1). Activity of
the phosphorylated PknB1-330-FKBP and PknB1-330-FRB was
confirmed by transphosphorylation of myelin basic protein,
a noncognate STPK substrate (Figure 1A). The phosphorylated
PknB1-330 fusion proteins displayed similar activities in the
absence or presence of rapamycin, and are not further activated
by an increase in KD concentration in the 10–50 nM range.
Addition of saturating rapamycin to a mixture of phosphorylated
PknB1-330-FKBP and PknB1-330-FRB resulted in dimerization
detectable by gel shift (Figure S2), but did not alter the phosphor-
ylation of myelin basic protein. These results suggest that
dimerization is not required for substrate phosphorylation
when the PknB KD is already phosphorylated.
Dimerization Activates Intermolecular PknB
Autophosphorylation
To test if dimerization affects the activity of the unphosphorylated
KD, PknB1-330-FKBP and PknB1-330-FRB purified from E. coli
were dephosphorylated using PstP, the Mtb Ser/Thr protein
phosphatase that antagonizes PknB (Boitel et al., 2003).
Autophosphorylation of unphosphorylated PknB1-330-FKBP or
PknB1-330-FRB individually is not affected by the presence or
absence of rapamycin (Figure 1B). When PknB1-330-FKBP and
PknB1-330-FRB are dimerized with rapamycin, however,
autophosphorylation is stimulated 4.7 ± 0.1-fold over the rapa-
mycin-free control (Figure 1C), indicating quantitatively that
dimerization activates unphosphorylated PknB.
To assess whether autophosphorylation results from inter-
molecular or intramolecular interactions, we measured the
dependence of the reaction rate on enzyme concentration.
An intramolecular reaction would display a simple linearAll rights reserved
Figure 1. Dimerization Regulates PknB
Activity
(A) Dimerization does not activate phosphorylated
PknB. Myelin basic protein is phosphorylated
similarly by phosphorylated PknB1-330-FKBP,
PknB1-330-FRB or an equimolar mixture of these
fusion proteins (PknB (FKBP + FRB)) in the pres-
ence (filled bars) or absence (open bars) of
10 mM rapamycin. Total kinase concentrations
are indicated. Error bars show the standard devia-
tion of three independent experiments. See also
Figure S2.
(B) Rapamycin does not affect autophosphoryla-
tion of isolated, unphosphorylated PknB1-330-
FKBP or PknB1-330-FRB. Autoradiogram showing
ª-32P incorporation into 4 mM of PknB-FKBP or
PknB-FRB incubated for 10 min (first four lanes)
or 20 min (last four lanes). The ratios of activities
with and without rapamycin are 1.0 ± 0.1 and
0.99 ± 0.1, respectively.
(C) Dimerization activates unphosphorylated
PknB. Autophosphorylation of unphosphorylated
PknB1-330-FKBP and PknB1-330-FRB in the
presence (filled circles) or absence (open circles)
of rapamycin. Error bars show the standard devia-
tion of three independent experiments.
(D) Kinase concentration dependence of auto-
phosphorylation rates reflects an intermolecular
reaction. Autophosphorylation rate is plotted
against kinase concentration for the mixture of un-
phosphorylated PknB1-330-FKBP and PknB1-330-
FRB in the presence (filled circles) or absence
(open circles) of rapamycin. Error bars show
the standard deviation of three independent
experiments.
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Allosteric Mechanism of PknB Activationdependence of reaction rate on enzyme concentration. The rate
of autophosphorylation for the combination of unphosphorylated
PknB1-330-FKBP and PknB1-330-FRB, however, exhibits a
nonlinear dependence on KD concentration in the presence
and absence of rapamycin (Figure 1D). This higher order concen-
tration dependence supports a rate-limiting intermolecular
phosphorylation mechanism both for the KD monomer and
dimer. This conclusion is consistent with the previous observa-
tion that the PknB KD can phosphorylate an inactive KD mutant
in a reaction that depends on intermolecular interactions through
the G-helix (Mieczkowski et al., 2008).
Dimerization Controls Phosphorylation through
an Allosteric Mechanism
The crystal structure of the PknB KD dimer revealed a number of
intermolecular interactions between invariant N-lobe residues,
including a salt bridge between Arg10 and Asp76 and hydro-
phobic contacts between Leu33 and both Asp76 and the C-helix
(Figure 2A). These classes of interactions are conserved not only
in PknB orthologs, but also in human PKR and closely related
kinases (Dey et al., 2005, 2007), suggesting that they are critical
for kinase structure and/or function. Substitutions of residues
in the predicted PknD KD N-lobe interface decrease kinase
activation in vitro (Greenstein et al., 2007). To determine if
PknB dimerization activates via allosteric effects that transmit
the N-lobe interactions to the active site, we assayed the
individual dimer-interface mutants Arg10Ala, Leu33Asp, andStructure 18, 1667–16Asp76Ala for autophosphorylation activity. Using the dephos-
phorylated PknB kinase fusions, rapamycin increased autophos-
phorylation of the Arg10Ala, Leu33Asp, and Asp76Ala mutants
only 1.8 ± 0.4, 3.1 ± 0.3, and 1.5 ± 0.03-fold, respectively (Fig-
ure 2B). Compared with the 4.7-fold increase of autophosphory-
lation of the wild-type KD in the presence of rapamycin, these
results support the idea that the N-lobe interface allosterically
activates the PknB KD.
Supporting this idea, we found using mass spectrometry
that the dimer-interface mutations also reduced autophosphor-
ylation of the KD fusions expressed in E. coli. While the predom-
inant wild-type PknB1-330-FKBP species carried six or seven
phosphates, the predominant Arg10Ala1-330-FKBP species
carried five phosphates and the Leu33Asp1-330-FKBP and
Asp76Ala1-330-FKBP species carried three or two phosphates
(Table 1). Further MS/MS analysis of trypsin digested
PknB fusions showed that the Leu33Asp1-330-FKBP and
Asp76Ala1-330-FKBP variants were phosphorylated at the posi-
tions in the activation loop known to be essential for activity,
Thr171 and Thr173 (Boitel et al., 2003), as well as Thr294 in the
juxtamembrane linker.
The idea that PknBKD is activated via an allostericmechanism
through the kinase N-lobe predicts that N-lobe interactions
will increase autophosphorylation even if one monomer within
the dimer is catalytically inactive (Greenstein et al., 2007).
To test this prediction, we inactivated the PknB KD by
replacing the catalytic Asp138 with Asn (Table 1). When77, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1669
Figure 2. The PknB N-Lobe Interface Is
Required for Efficient Autophosphorylation
and Substrate Phosphorylation
(A) Invariant residues Arg10, Leu33, and Asp76
form intermolecular contacts between PknB
monomers (gray and blue (left)) (PDB code:
1mru). Hydrogen bonds are indicated by dotted
lines. Reciprocal interactions include the Arg10-
Asp76 ion pair and Leu33 hydrophobic contacts
with Asp76 and the C-helix (top right).
(B) Mutations in the PknB N-lobe dimer interface
impair autophosphorylation and phosphorylation
of inactive PknB in vitro. Autoradiogram show-
ing autophosphorylation of unphosphorylated
PknB1-330 fusions (top) and transphosphorylation
of inactive Asp138Asn PknB1-308 KD (bottom).
Dimerization with the inactive Asp138Asn mutant
(D138N-FRB) activates the paired active subunit
(PknB-FKBP), indicating that the dimer interface
plays an allosteric role.
(C) Mutations in the PknB N-lobe dimer interface
impair substrate phosphorylation in vivo. Western
blots of M. smegmatis strains overexpressing
the indicated full-length Mtb PknB variant or
vector alone (pHR100) were probed using anti-
phosphoThr (a-pThr; top) or anti-PknB (a-PknB;
bottom) antibodies.
Structure
Allosteric Mechanism of PknB ActivationAsp138Asn1-330-FKBP and Asp138Asn1-330-FRB are combined,
no autophosphorylation is detected either in the presence
or absence of rapamycin (Figure 2B). However, in the
presence of active, unphosphorylated PknB1-330-FKBP, inactive
Asp138Asn1-330-FRBstimulates the autophosphorylation activity
by 3.7 ± 0.5-fold. Thus, N-lobe pairing of catalytically active and
inactive subunits stimulates kinase autophosphorylation.
N-Lobe Interface Mutations Decrease Substrate
Phosphorylation In Vitro and In Vivo
To test the effects of the interface mutations on substrate
phosphorylation, we quantified the phosphorylation of a shorter,
catalytically inactive PknB construct (Asp138Asn1-308), which is
separated easily from the longer, active PknB constructs. The
unphosphorylated wild-type PknB1-330 fusions phosphorylated
Asp138Asn1-308, and this activity was stimulated by rapamycin
(Figure 2B, bottom left). In contrast, the N-lobe interface muta-
tions in the KD fusions effectively eliminated phosphorylation of
Asp138Asn1-308 to yields of phosphorylated products compa-
rable to those observed using the inactive Asp138Asn1-3301670 Structure 18, 1667–1677, December 8, 2010 ª2010 Elsevier Ltd All rights reservedPknB fusions (Figure 2B). Partial activity
was observed when a functional
dimer interface was restored using an
active (PknB1-330-FKBP) and inactive
(Asp138Asn1-330-FRB) subunit. These
data demonstrate quantitatively that
in vitro substrate phosphorylation by
PknB depends on N-lobe dimerization.
To determine the role of the N-lobe
interface in vivo, we overexpressed
variants of full-length Mtb PknB in
the nonpathogenic mycobacterium,M. smegmatis. When phosphorylation wasmeasured bywestern
blotting with anti-phosphoThr antibodies, several cellular
substrates were detected (Figure 2C). These phosphorylation
levels were reduced upon expression of the catalytically inactive
Asp138Asn mutant, the dimer interface mutants Arg10Ala,
Leu33Asp, and Asp76Ala, or vector alone. Western blotting
using an anti-PknB antibody showed that the levels of PknB vari-
ants were similar in the overexpression strains. These data
suggest that the N-lobe dimer interface promotes substrate
phosphorylation and mediates activation of Mtb PknB in vivo.
Dimer-Interface Mutants Adopt Novel N-Lobe
Conformations
The dependence on N-lobe dimerization for allosteric PknB
activation suggests that the conformation of the monomeric
kinase should be inactive. To test this idea and to explore the
structural relationship between dimerization and activity, we
determined the crystal structures of two of the dimer-interface
mutants. Because the PknB1-330 construct used for biochemical
studies was more difficult to crystallize, mutations were
Table 2. Data Collection and Refinement Statistics for Mn:ATPªS-Bound PknB KD Mutant Structures
Leu33Asp-1a Leu33Asp-2 Leu33Asp-3 Asp76Ala
Data Collection
Space group P21 P212121 P212121 P212121
Unit cell dimensions
a, b, c (A˚) 80.93, 51.54, 141.41 39.34, 51.60, 155.13 40.19, 50.63, 132.74 40.46, 51.08, 134.75
Resolution (A˚) 2.0 1.6 2.9 2
Wavelength (A˚) 1.116 1.116 1.893 1.116
Rsym 0.097 (0.424) 0.034 (0.315) 0.087 (0.407) 0.070 (0.42)
I/sI 11.95 (2.25) 18.2 (3.4) 11.2 (3.1) 17.7 (2.5)
Completeness (%) 100 (100) 97.9 (88.2) 100 (99.9) 97.0 (96.5)
Solvent content (%) 37.5 43.9 34.6 38.6
Refinement
Rwork/Rfree 0.201/0.258 0.155/0.186 0.210/0.278 0.215/0.288
Rms bonds (A˚) 0.015 0.013 0.011 0.006
Rms angles () 1.58 1.52 1.0 1.1
Nonhydrogen atoms 9124 2593 2058 20
Solvent molecules 907 352 50 15
Metals 2 Mn2+ 1 Mn2+ 1 Mn2+ 1 Mn2+
Ordered protein residues/monomer 267 274 269 266
Other molecules Tris, SO4
Highest resolution shell is shown in parentheses. See also Table S1.
aContains four monomers in the asymmetric unit; number of metals and ordered protein residues refers to the values for a single monomer.
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Allosteric Mechanism of PknB Activationintroduced into PknB1-308 for structural studies (Young et al.,
2003). Unexpectedly, the Leu33Asp variant in complex with the
ATPanalog, ATPgS, yieldedmultiple distinct crystal forms,which
grew under identical or nearly identical conditions (Table S1).
These crystals formed similar lattices with comparable intermo-
lecular interactions. Here we describe four PknB dimer-interface
mutant structures: three structures of Leu33Asp PknB1-308
bound to ATPgS,Mn2+ at 2.9 A˚, 2.0 A˚, and 1.6 A˚ resolution (space
groups P212121, P21, and P212121, respectively) and one
structure of Asp76Ala PknB1-308 bound to ATPgS,Mn
2+ at 2.4 A˚
resolution (space group P212121). X-ray data-collection and
refinement statistics are presented in Table 2.
The structures clustered into three distinct conformations,
distinguished primarily by differences in the N-lobe (Figure 3A).
Conformation 1 (most similar to wild-type PknB) was found in
two monomers of Leu33Asp with 2 Mn2+ ions and the Asp76Ala
variant with a single Mn2+ ion coordinating the nucleotide. These
Leu33Asp KD structures occurred in the monoclinic crystal form
that contained four molecules representing two similar confor-
mations in the asymmetric unit. The two conformations, although
restrained by noncrystallographic symmetry throughout most of
refinement, differed by a slight rigid-body rotation of the N-lobe
(chains A and B, Ca root mean square deviation (rmsd) versus
wild-type PknB: 1.01 A˚, and chains C and D, Ca rmsd versus
wild-type PknB: 1.13 A˚). The Asp76Ala KD structure (Ca rmsd
versus wild-type PknB: 1.08 A˚) is very similar to chains A and
B of the Leu33Asp KD in conformation 1 (Figure S3). Conforma-
tion 2 (more structurally distinct from wild-type PknB; Ca rmsd:
1.76 A˚) and conformation 3 (most dissimilar from wild-type
PknB; Ca rmsd: 2.15 A˚) were observed for the Leu33Asp KD
mutant bound to a single Mn2+. Conformations 1 and 2 wereStructure 18, 1667–16reproduced in multiple Leu33Asp KD crystals containing either
manganese or magnesium and ATPgS or AMP-PNP (data not
shown).
In all the structures of these KD variants, PknB was mono-
meric, with no crystal contacts at the N-lobe interface containing
the substitution. The structures show a small domain closure
relative to the wild-type PknB KD and large shifts within the
N-lobe. Similar to most eukaryotic protein kinases, the primary
hinge for domain movement is in the linker between the N- and
C-lobe, corresponding to PknB residues 93–99. In each confor-
mation, backbone torsion-angle changes in this region account
for most of the domain shifts relative to the wild-type PknB KD.
Dimer-Interface Mutations Cause C-Helix
and Active Site Changes
The structural changes in the N-lobe altered the conformation of
residues 51–65, comprising the regulatory C-helix (Figure 3B).
The C terminus of this helix in wild-type PknB forms part of
the N-lobe dimer interface, and intersubunit interactions to the
C-helix are lost in the monomeric mutants. The C-helix carries
key residues of the active site and is thought to contact protein
substrates. In eukaryotic kinases, regulatory signals often toggle
the C-helix between characteristic active and inactive positions
(Huse and Kuriyan, 2002). In PknB KD conformation 1, the
C-helix rotates toward the C-lobe and into the active site, with
a displacement of 4 A˚ at the helix N terminus (Ser51) relative
to the wild-type PknB KD dimer. Conformation 2 exhibits 9 A˚
displacement of Ser51 compared with wild-type PknB due to
an unwinding of the last turn of the helix (alanine residues
63–65). Ala64 in this segment makes direct hydrophobic
contacts with Leu33 of the partner monomer in the WT dimer.77, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1671
Figure 3. Dimer Interface Mutations Cause
Conformational Changes in the PknB
N-Lobe and Active Site
(A) The monomeric Leu33Asp PknB KD shows
large structural changes in the N-lobe compared
with wild-type PknB. The dimeric wild-type PknB
KD (blue, one monomer shown) and four distinct
structures of the Leu33Asp KD (conformation 1
chain A: red; conformation 1 chain C: orange;
conformation 2: yellow; conformation 3: green)
are superimposed using the Ca atoms of C-lobe
residues 100–155 and 185–285. Nucleotide and
metals are omitted for clarity. See also Figure S3.
(B) The C-helix shifts downward toward the C-lobe
and inward toward the active site in the Leu33Asp
PknB KD structures (conformation 1 (c.1): red;
conformation 2 (c.2): yellow; conformation 3 (c.3):
green) compared with wild-type PknB (blue). The
C-terminal turn of the C-helix unwinds in the
Leu33Asp KD conformations 2 and 3, the Lys40-
Glu59 ion pair is broken and the C-helix N terminus
(right; Ser51) shifts up to 11 A˚. In concert, the
bound nucleotide shifts away from the active
conformation.
(C) Conformational changes occur in the active
site of the Leu33Asp PknB KD compared with
wild-type PknB. Each panel shows identical views
of Leu33Asp conformations 1, 2, and 3 (c.1, c.2,
and c.3) when the C-lobes are superimposed.
C-helix shifts break the Lys40-Glu59 ion pair and
couple directly to the DFG motif through contacts
of Phe157 with C-helix residues Ala63 and Ala64.
These multiple conformations suggest that the
monomeric PknB KD is more flexible than the
dimer.
Structure
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with a similar unwinding of the last turn of the helix and an 11 A˚
translational shift of Ser51.
Reorganization of the C-helix in the dimer-interface mutants
results in rearrangements of active-site residues that disrupt
key features that mediate catalytic activity. The conserved
Lys40-Glu59 ion pair, a hallmark of active STPKs (Huse and
Kuriyan, 2002; Johnson et al., 1996), was broken in all of the
dimer-interface mutant structures (Figure 3C). Lys40, which
coordinates the a- and b-phosphates of the nucleotide, is
stabilized in the active conformation by the close interaction
with Glu59. The Glu59 carboxylate rotates 45 away from
Lys40 in Leu33Asp conformation 1 and 90 away in conforma-
tions 2 and 3 compared with wild-type PknB (Figure 3B). As a
result, the conformation of Lys40 is variable in the mutant struc-
tures, allowing the nucleotide phosphates to bind in a nonpro-
ductive orientation in conformation 2.
Coincident with shifts in the C-helix, the conserved DFG
motif (Asp156-Gly158) adopts inactive conformations. Asp156,
which coordinates the primary metal ion (Mg1) and positions
the nucleotide b- and g-phosphates, shifts from gauche- in the
wild-type PknB KD to gauche+ in conformations 2 and 3 (Fig-1672 Structure 18, 1667–1677, December 8, 2010 ª2010 Elsevier Ltdure 3C). Phe157 shifts away from the ‘‘active’’ conformation
observed in the wild-type PknB KD dimer and a flip in the
Phe157main-chain carbonyl group accompanies these changes
in the side-chain position. In themonomer structures, the C-helix
shifts into the position that Gly158 occupies in the active KD
conformation.
The structures of the monomeric mutants also reveal changes
inmetal binding in the active site. In thewild-type PknB KD struc-
ture, the inner metal (Mg1) is bound by the b- and g-phosphates
of ATPgS and the carboxyl group of Asp156, while the outer
metal (Mg2) binds the a- and g-phosphates and the oxygen
Od1 of Asn143 (Young et al., 2003). In the N-lobe-interface
mutants, the second manganese ion (Mn2) is present only in
Leu33Asp conformation 1 (Figure 3C). In this conformation,
however, Mn2 is significantly shifted toward the interior of the
active site, positioning it only 3.8 A˚ away from Mn1. Subtle
shifts in residue positions preserve the coordination of Mn2. In
conformations 2 and 3 of the Leu33Asp PknB KD, the unwinding
of the last turn of the C-helix results in larger changes in the
active-site residues (Figure 3C). This reorganization appears to
be incompatible with binding both Mn2+ ions. The N-lobe and
nucleotide conformation tilt relative to the C-lobe and bringAll rights reserved
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Allosteric Mechanism of PknB ActivationAsn143 ‘‘beneath’’ the nucleotide where it coordinatesMn1. This
shift partially frees Asp156, which adopts a distinct rotamer with
only one carboxyl oxygen coordinating Mn1. These shifts
in comparison to the wild-type PknB KD eliminate the metal
coordination common to active STPK conformations.
The activation loop, which forms a substrate-binding platform
flanked by the DFG and APE motifs (SPE in PknB), also shows
large differences between wild-type PknB and the monomeric
mutants (Figure 3C). The ordered portion of the wild-type PknB
activation loop (residues 159–163) extends away from the active
site under the C-helix similar to the conformations observed in
active eukaryotic kinases. In the Leu33Asp and Asp76Ala PknB
KD structures, however, the activation loop extends past the
end of the C-helix in a different, relatively straight conformation.
The dimer-interface mutants show similar disorder in the activa-
tion loopcomparedwith thewild-typePknBKD,with no interpret-
able electron density for residues 164–178, 164–177 or 165–178
(conformation 1), 161–178 (conformation 2) or 160–178 (confor-
mation 3). This partial ordering contrasts with many inactive
eukaryotic kinases, where the activation loop assumes a folded,
protease-resistant conformation that blocks access to the ATP
binding site (Huse and Kuriyan, 2002; Nolen et al., 2004).
DISCUSSION
Protein interactions regulate STPKs by diverse mechanisms that
control the populations of the active and inactive conformations
of the KD. Here we characterized the role of the conserved,
back-to-back,N-lobedimer interface identified in thecrystal struc-
ture of the Mtb PknB KD (Ortiz-Lombardia et al., 2003;
Young et al., 2003). Our studies reveal that dimerization of
the unphosphorylated PknB KD through the N-lobe interface acti-
vates the kinase (autophosphorylation increases 5-fold in vitro)
via a distinctive allosteric mechanism. An intermolecular interac-
tion initiates autophosphorylation, as judged by the concentration
dependence of the reaction and the ability of the KD to phosphor-
ylate inactivesubunits. TheN-lobedimerpositions thePknBactive
sites away from each other, blocking access of the phosphoryla-
tion sites on one monomer to the active site of the other. This
geometry, togetherwith theability ofacatalytically inactivesubunit
to stimulate a wild-type partner, suggests that the dimer phos-
phorylates other dimers or monomers and the N-lobe contacts
stabilize the active conformation of the PknB KD.
PknB N-lobe dimerization stimulates autophosphorylation not
only in vitro; our data go beyond previous studies and suggest
that this interface mediates PknB activation in vivo. The overex-
pressed, full-length Mtb PknB stimulates phosphorylation of
endogenous proteins in M. smegmatis, and single substitutions
in theN-lobe dimer interface that impede KDdimerization reduce
or abolish this activity. Although the cellular protein phosphory-
lation stimulated by the expressed PknB can be direct or
indirect, these results directly link N-lobe dimerization to PknB
activation in mycobacteria.
Earlier work implicates a distinct C-lobe interface involving the
PknB G-helix in trans-autophosphorylation of the activation loop
(Mieczkowski et al., 2008). Taken together, these studies
suggest that two interfaces, the N-lobe contacts that activate
the KD and G-helix contacts in the C-lobe that mediate substrate
recognition, contribute to autophosphorylation.Structure 18, 1667–16Inactive Monomeric Bacterial STPK Structure
Previous structures of the PknB and PknE KD dimers left
open the question of the conformational effects of the N-lobe
intersubunit interactions. Our crystal structures of PknB KD
dimer-interface mutants reveal the monomeric conformations
of a bacterial STPK and explain the allosteric effects of dimeriza-
tion. Unlike a switch between unique active and inactive confor-
mations, the structural heterogeneity of the monomeric variants
in multiple crystal forms obtained under similar conditions indi-
cates that the PknB KD monomers are more flexible than the
active dimer. The loss of direct intersubunit contacts destabilizes
the last turn of the C-helix, which provides the mechanism of
communication between the dimer interface and the active
site. The release of the C-terminal anchor of the C-helix propa-
gates and telescopes small structural changes (1.5–3 A˚) at
the mutation sites to changes of up to 11 A˚ at the C-helix
N terminus, >30 A˚ from the Leu33 substitution. These shifts at
the active site rupture critical interactions required for substrate
binding and catalysis. Thus, the structural polymorphism of the
monomers reveals that the N-lobe dimer interface selects the
active conformation by stabilizing particular productive features
while maintaining flexibility in segments that move during
turnover.
Comparison to Inactive Conformations
of Eukaryotic Kinases
The activation mechanism of PknB represents an unprece-
dented conformational transition in the kinase family. In the
PknB KDmonomer mutant structures, the C-helix moves toward
the active site, a shift opposite to the direction seen in most
inactive eukaryotic kinases (Figure 4). In the inactive, nucleo-
tide-bound structures of CDK2 (Brown et al., 1999), Src
(Cowan-Jacob et al., 2005), and EGFR (Zhang et al., 2006), for
example, the C-helix is swung back and away from the active
site, increasing the distance between the essential lysine-gluta-
mate ion pair. This inactive conformation is often maintained by
other parts of the structure, such as direct interactions of the un-
phosphorylated activation loop with the C-helix that block helix
movement. By contrast, in conformation 1 of the Leu33Asp
and Asp76Ala PknB KDs, the orientation of the C-helix relative
to the C-lobe differs by 30 compared with the CDK2 and Src
inactive states, and the tilting of the C-helix moves Glu59 away
from a productive conformation. In conformations 2 and 3, the
unwinding of the last turn of the C-helix also couples to distinc-
tive shifts in this helix and the DFG motif. On the other hand, the
active conformations of wild-type PknB (Young et al., 2003) and
the eukaryotic kinases CDK2 (Russo et al., 1996), Src (Sicheri
et al., 1997), EGFR (Zhang et al., 2006), PKR (Dar et al., 2005),
and Ire1 (Lee et al., 2008) contain similar orientations of the
C-helix and N-lobe (Figure 4). Thus, release of the PknB N-lobe
intersubunit contacts increases the flexibility of the KD, which
populates distinctive inactive conformations.
PknB Regulation Model
Although no structures of theMtb PknD KD have been reported,
the finding that N-lobe dimerization also activates the PknD KD
in vitro (Greenstein et al., 2007) suggests that back-to-back
pairing may regulate multiple mycobacterial receptor STPKs.
Our quantitative measurements showing that dimerization77, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1673
Figure 4. Unique Conformational Changes Inacti-
vate PknB Compared with Eukaryotic Kinases
The C-helix of monomeric, inactive PknB shifts in the
opposite direction as eukaryotic kinases. Superposition
of inactive (left) and active (right) kinase conformations of
PknB (blue; Leu33Asp conformation 1 and 1mru), CDK2
(red; 1b38 and 1jst), Src (yellow; 1y57 and 1ad5), EGFR
(green; 2gs7 and 2gs6), PKR (orange; no inactive structure
and 2a19), and Ire1 (violet; no inactive structure and 2rio).
Structure
Allosteric Mechanism of PknB Activationhelps activate the unphosphorylated KD supports a stepwise
model for regulation of PknB and PknD (Figure 5). The unphos-
phorylated KD monomer represents the inactive form. Dimeriza-
tion promoted, for example, by ligand binding to the extracellular
domain, rigidifies the KD dimer N-lobe and stabilizes the active
kinase conformation. This activation facilitates intermolecular
autophosphorylation, which produces a fully active kinase
domain that can phosphorylate substrates. When the extracel-
lular dimerization signal dissipates, the phosphorylated kinase
remains active. The PstP phosphatase antagonizes activation
by dephosphorylating the KD (Boitel et al., 2003).
We hypothesize that ligand binding to the PknB extracellular
sensor domain promotes dimerization. The eukaryotic kinases
PKR and Ire1, which form similar KD dimers but have unrelated
sensor-domain architectures, are both activated by oligomeriza-
tion promoted by ligand binding. The self-association of the
isolated PknB and PknE KDs is very weak (low mM range)
(Gay et al., 2006), and the isolated, extracellular sensor domains
of PknB, PknD, and PknE kinases are all monomers at typical
protein concentrations in solution (data not shown; Barthe
et al., 2010; Good et al., 2004), suggesting that neither the
receptor KDs nor the sensor domains dimerize without added1674 Structure 18, 1667–1677, December 8, 2010 ª2010 Elsevier Ltd All rights reserveligands. Although the ligand that initiates PknB
activation is unknown, the sensor domain con-
tains PASTA domains thought to bind unlinked
peptidoglycan fragments (Shah et al., 2008).
Implications for Other STPKs
This regulatory mechanism shared byMtb PknB
and PknD (Greenstein et al., 2007) has several
important and versatile features. The activity of
the phosphorylated monomer can amplify
external signals and enable phosphorylation tocontinue after the dimerization signal has dissipated. In addition,
the intermolecular character of KD phosphorylation supports the
idea that STPKs phosphorylate and activate other kinases in the
cell. The finding that PknB can phosphorylate PknA exemplifies
this kind of kinase network (Kang et al., 2005). This suggests that
crosstalk between Mtb STPKs may form specific signaling
networks with multiple combinations of inputs and phosphoryla-
tion outputs. As a result, responses to specific ligands could be
tuned by the combination of ligand affinity, intermolecular
binding, and the geometry of kinase binding sites in the signaling
molecule.
The nine receptor kinases in Mtb cluster into three sequence
clades, each containing three members (Greenstein et al.,
2007). The N-lobe interface sequences are conserved within
each clade, raising the possibility that kinases within a clade
could form functional allosteric heterodimers. This idea has not
been tested, however, and potential ligands that could bring
together different STPKs remain to be defined.
Especially in light of the similarities to the structurally divergent
PknD (Greenstein et al., 2007) and our demonstration that PknB
dimer interface mutants fail to mediate protein phosphorylation
in M. smegmatis, the general features of the PknB regulationFigure 5. Model for PknB Regulation
(1) The unphosphorylated PknBmonomer (kinase domain:
dark blue) is the inactive species. (2) Dimerization,
possibly mediated by ligand binding (violet) to the extra-
cellular PASTA domains (gray), activates the intracellular
kinase domains, (3) triggering intermolecular autophos-
phorylation (kinase domain: cyan) and subsequent
transphosphorylation of substrates. (4) Upon dimer disso-
ciation, phosphorylated kinase monomers amplify the
signal and remain active until (5) dephosphorylation by
the Mtb Ser/Thr protein phosphatase, PstP, regenerates
the inactive, unphosphorylated monomer.
d
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Allosteric Mechanism of PknB Activationmechanism are likely to be conserved in homologous bacterial
receptor STPKs. The PknB orthologs in Bacillus subtilis, PrkC,
and Streptococcus pneumoniae, StkP, are predicted to have
conserved N-lobe surfaces similar to PknB. Although the struc-
tures of these bacterial STPKs have not been reported, these
proteins form dimers in vivo, involving the extracellular PASTA
domains and the transmembrane domain (Madec et al., 2002;
Pallova et al., 2007). Importantly, ligand-promoted dimerization
of an engineered Pseudomonas aeruginosa receptor kinase,
PpkA, fused through the extracellular C terminus to a FKBP
variant activates the kinase in vivo (Mougous et al., 2007). These
biochemical and microbiological studies provide support for
a general role for N-lobe dimerization in activating bacterial
receptor STPKs.
The flexibility of the PknB monomer structures may represent
a broader mechanism for regulation applicable to structurally
similar eukaryotic protein kinases. Mtb PknB, human PKR, and
human Ire1 form N-lobe dimers with striking similarities. Like
PknB, dimerization through theN-lobe interface activates human
PKR (Dey et al., 2005).Monomeric, inactive PKR is susceptible to
proteolysis of the activation loop (Anderson and Cole, 2008),
suggesting that the inactive conformation of the PKR and
PknB activation loops are similarly disordered and positioned
away from the active site. The functional and structural similari-
ties between PknB and PKR support the hypothesis that the
inactive PKR monomer will have structural similarities to mono-
meric, inactive PknB. Although the Ire1 and PknB KD dimers
stabilize particular features of the KD structures (Lee et al.,
2008; Young et al., 2003), the functions of these dimers appear
to be somewhat different. Rather than activating the KD, as in
PknB, the Ire1 dimer acts as a scaffold to promote assembly of
a larger oligomer that enhances the activity of the appended
ribonuclease domains on cognate substrates (Korennykh et al.,
2009). Distinct from Ire1, the phosphorylated PknB KD is not
further activated by an increase in dimer concentration, support-
ing the idea that PknB does not function as a higher order olig-
omer. While bacterial STPKs may form complexes with other
proteins (Mougous et al., 2007), the available data suggest that
activated PknB functions as either a monomer or dimer.
Overall, our work reveals the structural ensemble of the inac-
tive monomer of a bacterial STPK and provides insights into
unanticipated mechanisms of protein kinase regulation. This
window into the structural and functional implications of STPK
dimerization sheds light on key control mechanisms that may
open new avenues for therapeutic intervention in tuberculosis.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
Expression vectors for Mtb PknB1-330, PstP, and PknB1-308 were described
previously (Grundner et al., 2005; Pullen et al., 2004; Young et al., 2003).
Expression vectors for the PknB-FKBP and -FRB fusions were generated as
described (Greenstein et al., 2007), except the fusion constructs were intro-
duced into a modified pET-28b vector encoding an N-terminal His tag and
tobacco etch virus (TEV) cleavage site. Mutations were introduced using the
QuikChangemethod (Stratagene). PknB1-308, PknB1-330, PknB fusion proteins,
PknB variants and PstP were expressed and purified as described (Greenstein
et al., 2007; Grundner et al., 2005; Pullen et al., 2004; Young et al., 2003). His
tags of the PknB fusions and PknB1-308 variants were cleaved by incubation
with TEV and thrombin, respectively, and removed with a second Chelating
Sepharose HP column (GE Healthcare). The PknB1-308 Asp138NAsn,Structure 18, 1667–16Leu33Asp, and Asp76Ala variants were purified further by gel-exclusion
chromatography on a HiLoad 26/60 Superdex 75 column (GE Healthcare)
and by ion exchange chromatography with a HiTrap Q HP column (GE Health-
care) using an elution gradient of 75–500 mM NaCl. The PknB fusions were
dialyzed into 75–150 mM NaCl, 50 mM HEPES (pH 7.5), and 0.5 mM TCEP.
Other proteins were dialyzed into 75 mM NaCl, 20 mM Tris (pH 7.5), and
0.5 mM TCEP.
In Vitro Kinase Assays
To test the effect of dimerization on phosphorylation, phosphorylated KDs
purified from E. coli, PknB-FKBP, or PknB-FRB fusions (10 nM each) or the
combination of the two (10, 25, or 50 nM total) were incubated in 20 ml of
20 mM Pipes (pH 7.5), 75 mM NaCl, 1 mM DTT, 2 mM MnCl2, 54 mM myelin
basic protein, and 10 mM rapamycin in ethanol or the equivalent volume of
ethanol at 4C for 2 hr. Reactions were initiated by adding ATP to 50 mM
supplemented with 5 mCi g32P-ATP. Reactions were quenched after 30 min
at room temperature using SDS loading buffer supplemented with 0.2 M
DTT and 0.1 M EDTA. Samples were separated on 4%–12% NuPAGE
Bis-Tris gels by SDS-PAGE, dried, and exposed to a Molecular Dynamics
Typhoon 8600 PhosphoImager. 32P incorporation was quantified with
ImageQuant 5.2.
To dephosphorylate the PknB fusion proteins, a mixture of 1:10 (w/w)
His6-PstP:KD was incubated at 25
C in 2 mM MnCl2 in 50 mM HEPES
(pH 8.0) and 1 mM TCEP. PstP was removed with Ni-Sepharose resin. The
complete removal of phosphoryl groups was confirmed by western blotting
using anti-pThr antibody (Zymed Laboratories) or mass spectrometry.
To detect autophosphorylation, dephosphorylated PknB-FKBP and
PknB-FRB or mutants (2 mM total kinase or amount indicated) were incubated
with 50 mM NaCl, 50 mM HEPES (pH 7.5), 0.5 mM TCEP, 2 mM MnCl2, and
10 mM rapamycin (Sigma-Aldrich) in ethanol or an equivalent volume of ethanol
for 25 min at room temperature. 100 mM ATP supplemented with 5 mCi of
g32P-ATP was added to initiate the 20 ml reactions. After the indicated times
or 6 min for the rate measurements, reactions were quenched with SDS
loading buffer and analyzed as described above for the phosphorylated kinase
assays. Rapamycin-induced changes in activity were calculated using time
points of 2, 4, and 8 min. To detect transphosphorylation, PknB-FKBP and
PknB-FRB or mutants (1 mM total kinase) were incubated with 20 mM
Asp138Asn PknB1-308. Rapamycin-induced changes in activity were calcu-
lated at 10, 20, and 40 min.
M. smegmatis Strains, Media, and Growth Conditions
The full-lengthMtb PknB gene was amplified from H37Rv genomic DNA (CSU
TB Vaccine Testing and Materials Contract) and cloned into pJSC232 (Jeffery
Cox, UCSF). PknB variants were cloned into the mycobacterial expression
plasmid pHR100 (Jeffery Cox, UCSF). Plasmids were electroporated into
M. smegmatis mc2155 and verified by DNA sequencing. M. smegmatis
cultures were grown at 37C in 7H9 Middlebrook medium (Difco) supple-
mented with 0.5% [w/v] dextrose, 0.5% [v/v] glycerol, and 0.05% [w/v]
Tween-80 or on Middlebrook 7H10-agar (Difco) plates with the same supple-
ments. Plasmids were maintained by growth in medium containing kanamycin
(20 mg/ml).
Phosphorylation and Protein Detection inM. smegmatis Strains
Protein phosphorylation and the levels of PknB variants were determined
by immunoblot analysis. M. smegmatis cells harboring pHR100-PknB,
pHR100-PknB R10A, pHR100-PknB Leu33Asp, pHR100-PknB Asp76Ala,
pHR100-PknB Asp138Asn, or pHR100 vector alone were grown to mid-log
phase (OD600 = 0.8) and diluted to OD600 = 0.02 in 25 ml medium containing
0.2% (w/v) acetamide. After one doubling time, cells were harvested by centri-
fugation, resuspended in extraction buffer (1% SDS, 20 mM EDTA, 50 mM
HEPES [pH 7.5], and 1 mM AEBSF), and bead beaten for 2 min at 4C. 1 mg
of protein from each strain was separated by a 12%Tris-glycine gel (Invitrogen)
and analyzed by western blotting using rabbit anti-pThr antibodies (Zymed
Laboratories) or rabbit anti-PknB KD antibodies (Pacific Immunology).
Mass Spectrometry
Analysis of kinase-domain phosphorylation states by mass spectrometry was
performed as described (Young et al., 2003).77, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1675
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Allosteric Mechanism of PknB ActivationCrystallization, Data Collection, Processing, and Crystallographic
Refinement
Leu33Asp and Asp76Ala PknB1-308 variants were crystallized at 4
C by vapor
diffusion from 10 mg/ml protein, 2 mM ATPªS, and 2 mM MnCl2 mixed 1:1
with precipitant. Table S1 shows the crystallization conditions and cryoprotec-
tants for the PknB mutants. Before data collection, crystals were soaked for
1–15 min in the mother liquor plus 10%–16% glycerol (or 30% PEG3350 for
Asp76Ala) and 2 mM MnCl2, and frozen in liquid nitrogen.
X-ray diffraction data were collected at the ALS beamline 8.3.1 at 100 K and
11,111 eV or 6551 eV. Data were processed using the Elves automation
program (Holton and Alber, 2004). Structures were solved by molecular
replacement using the ATPgS-bound wild-type PknB KD (Young et al., 2003)
as the search model in EPMR or Molrep (Kissinger et al., 1999; Vagin and Te-
plyakov, 2000). Rigid-body refinement with REFMAC (Murshudov et al., 1997)
and/or simulated annealing with CNS (Brunger et al., 1998) were used prior to
manual rebuilding. High-resolution structures were rebuilt using ARP/wARP
(Perrakis et al., 1999). Models were further improved usingO andCoot (Emsley
and Cowtan, 2004; Jones et al., 1991) and refined using REFMAC and phenix.-
refine (Adams et al., 2010), with separate TLS parameters for the N andC lobes
(Winn et al., 2001). For crystals containing Mn2+, the number and positions of
the metals were verified using anomalous difference electron density maps
calculated with data collected above the Mn2+ absorption edge.ACCESSION NUMBERS
Coordinates and structure factors for the models of the PknB Leu33Asp
(conformations 1, 2, and 3) and Asp76Ala variant KDs have been assigned
Protein Data Bank accession numbers 3ORI, 3ORK, 3ORL, and 3ORM,
respectively. We also deposited coordinates and structure factors for three
PknB Leu33Asp conformations (3ORO, 3ORP, and 3ORT) obtained in the
absence of bound divalent ions in crystals grown from high concentrations
of the chelator, citrate. Although these metal-free structures may not be
significantly populated in vivo, they confirm the flexibility of the Leu33Asp
mutant KD.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at doi:10.1016/j.str.2010.09.019.
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